Rishi Gupta - 23 Feb 2023 Form 3 Insider Report for Enliven Therapeutics, Inc. (ELVN)

Role: Director, 10%+ Owner
Signature: /s/ Ben Hohl, by power of attorney
Issuer symbol: ELVN
Transactions as of: 23 Feb 2023
Transactions value $: $0
Form type: 3
Filing time: 27 Feb 2023, 20:48:31 UTC
Previous filing: 27 Dec 2022
Next filing: 28 Apr 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney